Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Year: 2017
Type: letter
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1615712
Authors: Franco Cosmi, Roberto Laini, Antonio Nicolucci
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novo Nordisk Fonden
Awards: G1551214306, G2790715585, G4899559972
OpenAlex ID: W3049003652
